Nimadel - P is a meticulously formulated combination tablet designed to deliver synergistic therapeutic effects through its dual active ingredients: Nimesulide (100mg) and Paracetamol (325mg). The formulation leverages the anti-inflammatory and analgesic properties of Nimesulide, a selective COX-2 inhibitor, alongside the rapid-acting pain-relieving effects of Paracetamol. The tablet is manufactured using advanced excipient blends, including disintegrants, binders, and coatings, to ensure optimal disintegration, uniform drug distribution, and stability under varied storage conditions. The formulation process adheres to strict pharmaceutical guidelines to maintain bioavailability, dissolution rates, and compatibility between the two active pharmaceutical ingredients (APIs). The final product is a robust, solid dosage form suitable for oral administration, with a focus on consistent potency, tablet hardness, and surface smoothness to meet global quality standards.
Manufacturing Capability
Delwis Healthcare’s manufacturing infrastructure is equipped to produce Nimadel - P with precision and scalability, leveraging state-of-the-art facilities compliant with current Good Manufacturing Practices (cGMP). The production process employs high-speed tablet presses, automated blending systems, and advanced coating technologies to ensure uniformity in tablet weight, thickness, and coating integrity. The facility is designed for non-sterile tablet manufacturing, with dedicated areas for API handling, granulation, compression, and packaging. Quality systems include real-time monitoring of critical process parameters such as compression force, tablet disintegration time, and moisture content. The manufacturing capacity supports large-scale production, with the ability to scale up or down based on demand while maintaining consistency in product quality. Rigorous validation protocols, including process analytical technology (PAT) tools, ensure compliance with pharmaceutical standards and minimize variability in batch output.
Available Strengths and Packaging
Composition: Nimesulide 100mg + Paracetamol 325mg Tab.
Packaging: 20x10 Blister
Nimadel - P is available in a single strength formulation, combining Nimesulide 100mg and Paracetamol 325mg in a single tablet. The blister packaging (20x10) ensures tamper-evident storage, protection from environmental contaminants, and ease of distribution. This packaging format is ideal for pharmaceutical manufacturers requiring secure, shelf-stable packaging for domestic and international markets.
Contract Manufacturing / Third Party Manufacturing
As a trusted manufacturer, Delwis Healthcare offers comprehensive third-party manufacturing services, including private label production and contract manufacturing for pharmaceutical buyers. Our capabilities extend to full-cycle production, from API sourcing and formulation development to packaging and labeling, ensuring end-to-end compliance with regulatory standards. We provide flexible manufacturing solutions tailored to the specific needs of global buyers, including customized packaging formats, dosage strengths, and labeling requirements. Our contract manufacturing division supports both small and large-scale orders, with dedicated quality control teams to ensure consistency and adherence to client specifications. This service is ideal for pharmaceutical distributors, exporters, and brand owners seeking to outsource production while maintaining control over product quality and regulatory compliance.
Quality Assurance
Delwis Healthcare’s quality assurance framework is built on rigorous testing, analytical validation, and adherence to international pharmaceutical standards. Each batch of Nimadel - P undergoes comprehensive quality control checks, including high-performance liquid chromatography (HPLC) for API content verification, dissolution testing to ensure bioavailability, and physical testing for tablet hardness, disintegration time, and weight uniformity. Analytical validation protocols confirm the accuracy, precision, and reproducibility of test methods, ensuring data integrity. Our quality systems are aligned with ICH guidelines, FDA regulations, and WHO standards, with regular internal audits and third-party inspections to maintain compliance. All raw materials and finished products are tested for microbial contamination, heavy metals, and particulate matter, ensuring safety and efficacy for global markets.
Regulatory Compliance
Delwis Healthcare ensures full compliance with global regulatory frameworks, including cGMP, WHO guidelines, ISO 9001:2015, and regional pharmacopeia standards. Our manufacturing facilities are certified under ISO 17025 for testing laboratories and ISO 27001 for information security management. The company maintains compliance with FDA, EMA, and PIC/S requirements for pharmaceutical production, with documentation and audit trails to support regulatory inspections. Nimadel - P is manufactured in accordance with WHO’s guidelines for quality control of medicines, ensuring adherence to international standards for safety, efficacy, and quality. Regulatory compliance is integrated into every stage of production, from raw material sourcing to final packaging, ensuring that products meet the requirements of target markets and facilitate seamless export processes.
Global Supply Capability
Delwis Healthcare possesses robust global supply capabilities, with an extensive international distribution network and the ability to supply bulk quantities to meet large-scale demand. Our export infrastructure supports seamless logistics, including customs compliance, documentation, and shipping arrangements for pharmaceutical products. The company maintains strategic partnerships with logistics providers to ensure timely delivery to over 50 countries, with a focus on reliability and compliance with import regulations. Bulk supply capacity is optimized through automated storage and distribution systems, enabling efficient handling of large orders without compromising quality. Our supply chain is designed for resilience, with contingency plans to address disruptions while maintaining uninterrupted service to pharmaceutical buyers worldwide.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners choose Delwis Healthcare for its commitment to quality, regulatory compliance, and scalable production. Our expertise in manufacturing complex combination products like Nimadel - P ensures that clients receive a reliable, high-quality product with minimal lead times. The company’s global supply network and adherence to international standards make it an ideal partner for businesses seeking to enter new markets or expand their product portfolios. With a focus on innovation, transparency, and customer-centric solutions, Delwis Healthcare provides the tools and support needed to succeed in the competitive pharmaceutical industry.
Bulk Supply Inquiry
Delwis Healthcare offers competitive bulk supply options for Nimadel - P. For inquiries regarding large-scale orders, pricing, or customized packaging solutions, please contact our team at info@delwishealthcare.com.
FAQs
What regulatory standards does Nimadel - P comply with?
Nimadel - P is manufactured in full compliance with cGMP, WHO guidelines, ISO 9001:2015, and regional pharmacopeia standards, ensuring adherence to global regulatory requirements.
Can Nimadel - P be produced in different packaging formats?
Yes, Delwis Healthcare offers flexible packaging solutions, including blister packs, bottles, and cartons, to meet the specific needs of pharmaceutical buyers.
What is the shelf life of Nimadel - P?
The shelf life of Nimadel - P is typically 24 months when stored under recommended conditions, as confirmed by stability testing and regulatory guidelines.
Does Delwis Healthcare provide contract manufacturing services for Nimadel - P?
Yes, we offer end-to-end contract manufacturing services, including formulation development, API sourcing, and packaging, tailored to client specifications.
How does Delwis Healthcare ensure quality during the manufacturing process?
Our quality assurance system includes HPLC testing, dissolution analysis, and rigorous batch validation to ensure consistency, safety, and compliance with pharmaceutical standards.
Can Nimadel - P be exported to international markets?
Yes, our global supply network and compliance with international regulations enable seamless export to over 50 countries, including the EU, US, and Asia-Pacific regions.
What is the minimum order quantity for bulk supply?
We accommodate bulk orders starting from 10,000 units, with flexible production scaling to meet large-scale demand.
How can I request a sample of Nimadel - P?
Samples can be requested by contacting our sales team at info@delwishealthcare.com, with details on product specifications and packaging requirements.
What certifications does Delwis Healthcare hold?
Our facility is certified under ISO 17025, ISO 27001, and cGMP, with regular audits to maintain compliance with international standards.
Can Delwis Healthcare support private label manufacturing for Nimadel - P?
Yes, we provide private label manufacturing services, allowing clients to brand the product under their own label while maintaining quality and regulatory compliance.
